Please read this first. Diabetic neuropathy is a serious medical condition, and nerve pain is exhausting to live with — which is exactly why it attracts so much hopeful, overstated marketing. This page will not tell you that a supplement fixes nerve damage, because the evidence does not say that. It tells you, plainly, what the research supports, what it doesn't, and why the things that genuinely protect your nerves sit with your medical team, not in a supplement bottle.
Disclosure. Some links on this page are affiliate links, including Amazon links. PureNovus participates in the Amazon Services LLC Associates Program and, as an Amazon Associate, earns from qualifying purchases — at no extra cost to you, and with no influence on what is recommended or how the evidence is assessed.
Diabetic peripheral neuropathy is nerve damage caused, over time, by high blood sugar. It most often shows up as numbness, tingling, burning, or pain in the feet and hands. It affects a large share of people with diabetes, and it is the kind of problem where false hope is genuinely harmful: chasing a supplement instead of proper care can let nerve damage and foot complications progress quietly.
So the honest hierarchy, before any supplement: the single most effective thing shown to slow neuropathy is bringing blood sugar into a healthy range, alongside blood-pressure control, not smoking, and daily foot care. For the pain itself, the treatments with real evidence are prescription medications your doctor can offer (such as duloxetine, pregabalin, or gabapentin). [8] Supplements, at their best, are modest add-on symptom support for some people — not a treatment for the underlying nerve damage, and not a substitute for any of the above.
With that frame, here is what the evidence actually shows for the supplements most often studied.
Vitamin B12 — start here, especially on metformin
Evidence: Strong for one specific situation — correcting a deficiency.
This is the most useful and most overlooked point on the page, so it goes first. Long-term use of metformin — the most common first-line diabetes medication — lowers vitamin B12 over time. A large analysis from the All of Us research program found long-term metformin users had markedly higher rates of B12 deficiency than non-users, with the risk rising the longer the medication is taken. [1] And B12 deficiency causes its own nerve symptoms that can look exactly like, or worsen, diabetic neuropathy. For this reason, the American Diabetes Association recommends periodic B12 testing for people on long-term metformin, particularly anyone with neuropathy symptoms or anemia. [2]
The practical takeaway is genuinely actionable: if you are on metformin and have nerve symptoms, ask your doctor for a simple B12 blood test. If you are low, correcting it can directly help — and it is cheap and safe to do. The honest caveat is the flip side: B12 helps the symptoms that are caused by B12 deficiency. If your levels are normal, taking more is very unlikely to do anything for your nerves. This is a "test, then treat" situation, not a "take it just in case" one.
If a test shows you're low (or your doctor recommends it), a clean single-ingredient option is Nature Made Vitamin B12 1000 mcg — it carries the USP Verified mark, the strongest third-party seal. (Affiliate link — see the disclosure at the top of this page.) Keep the order of operations in mind: test first. Extra B12 won't help nerve symptoms if your levels are already normal.
Alpha-lipoic acid (ALA)
Evidence: Moderate for symptoms — the most-studied option, with limits.
Alpha-lipoic acid is an antioxidant and the supplement with the most research behind it for diabetic nerve symptoms. The strongest evidence is for the intravenous form given in clinical settings: pooled trials show clinically meaningful short-term improvement in symptoms like pain, burning, and numbness. [3] Oral ALA — the form you would actually buy — also shows benefit in trials, but the effect is more modest and the evidence less consistent; the largest long-term oral study (the four-year NATHAN 1 trial) found improvements in nerve impairment measures but a mixed picture overall. [3][4]
What that adds up to: oral ALA is a reasonable thing for some people to try for symptom relief, with realistic expectations — it may take weeks, the benefit is usually modest, and it does not repair the underlying nerve damage. It is generally well tolerated. Because it can nudge blood sugar down, anyone on glucose-lowering medication should mention it to their doctor, and it is usually taken away from meals and separated from thyroid medication.
A clean option, if you want one: Nutricost Alpha Lipoic Acid — single-ingredient, Non-GMO, transparent label. (Affiliate link — see the disclosure at the top of this page.) Set expectations realistically: any benefit is usually modest and takes weeks. Because ALA can lower blood sugar, mention it to your doctor if you're on glucose-lowering medication, and it's typically taken away from meals.
Acetyl-L-carnitine (ALC)
Evidence: Weak to moderate — possible modest pain relief, low-certainty.
Acetyl-L-carnitine has been studied for nerve pain, including in diabetes. Some randomised trials report a modest reduction in pain and even signs of nerve-fiber regeneration. [5] However, a Cochrane review — the most rigorous kind of summary — rated the overall certainty of this evidence as low, meaning the true effect could be smaller than it looks, or absent. [6] It is generally well tolerated, with digestive upset the most common complaint. It is fair to describe ALC as "possibly helpful for pain in some people, on weak evidence" — which is a very different claim from the ones you will see on supplement labels.
If you want to try it: Nutricost Acetyl L-Carnitine (ALCAR) — a plain, single-ingredient option. (Affiliate link — see the disclosure at the top of this page.) Set expectations accordingly: the evidence here is weaker and lower-certainty than for the options above, so treat it as an experiment — give it a fair trial and drop it if you notice no difference. Talk to your doctor first, especially if you take thyroid medication or a blood thinner.
Benfotiamine and the others
Evidence: Weak.
Benfotiamine is a fat-soluble form of vitamin B1 (thiamine). A few small trials have suggested it may ease symptoms, but the studies are limited, short, and mixed, so it sits firmly in "promising but unproven." [7] Beyond it, the typical "neuropathy support" formulas combine B vitamins, ALA, and assorted botanicals — often as proprietary blends at doses you can't verify, wrapped in strong promises. Those blends are exactly what to be sceptical of: you pay more, you can't tell how much of anything you're getting, and the marketing routinely outruns the science. If you try anything here, single-ingredient products you can actually dose and verify are the more honest route.
Safety and honest expectations
- Do not let a supplement delay real care. New, worsening, or one-sided numbness, pain, weakness, or any wound, blister, or color change on the feet needs prompt medical attention — not a supplement and a wait-and-see.
- Watch for interactions and low blood sugar. Alpha-lipoic acid can lower glucose; several of these can interact with medications. Anyone on diabetes medication should loop in their doctor or pharmacist before adding anything.
- Quality varies widely. Supplements are loosely regulated. Favor products with third-party verification (USP, NSF) or published independent testing, and avoid proprietary blends that hide doses.
- Expectations should be modest. Even the better-supported options offer symptom support for some people, not nerve repair. If something isn't clearly helping after a fair trial, stopping is reasonable.
What actually protects your nerves
It is worth ending where the evidence is strongest, because it is also the least-marketed. Keeping blood sugar in a healthy range is the one intervention repeatedly shown to slow the progression of diabetic neuropathy. Add to that: managing blood pressure, not smoking, moving regularly, and inspecting and caring for your feet daily so small problems are caught early. For pain that needs treating, your doctor has medications with real evidence behind them. Supplements can be a small, optional layer on top of that foundation — never a replacement for it. [8]
When to speak with a doctor
This page is educational and is not medical advice. Please speak with a healthcare provider before starting any supplement, and promptly if you have new or worsening nerve symptoms, any foot wound or infection, or sudden weakness. If you are on metformin and have neuropathy symptoms, asking for a vitamin B12 test is a reasonable, concrete first step. None of the information on this site is intended to diagnose, treat, cure, or prevent any disease.
References
- Sepassi A, Wang J, et al. Associations between long-term metformin use, the risk of vitamin B12 deficiency, and neuropathy: An All of Us Research Program study. Diabetes Research and Clinical Practice, 2025.
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes — 2024. Diabetes Care, 2024; 47 (Supplement 1).
- Mijnhout GS, Kollen BJ, Alkhalaf A, Kleefstra N, Bilo HJG. Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials. International Journal of Endocrinology, 2012; 2012: 456279.
- Ziegler D, Low PA, Litchy WJ, et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care, 2011; 34(9): 2054–2060.
- Sima AAF, Calvani M, Mehra M, Amato A. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care, 2005; 28(1): 89–94.
- Rolim LCSP, da Silva EMK, Flumignan RLG, Abreu MM, Dib SA. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. Cochrane Database of Systematic Reviews, 2019; 6: CD011265.
- Stracke H, Gaus W, Achenbach U, Federlin K, Bretzel RG. Benfotiamine in diabetic polyneuropathy (BENDIP): a randomised, double-blind, placebo-controlled clinical study. Experimental and Clinical Endocrinology & Diabetes, 2008; 116(10): 600–605.
- Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care, 2017; 40(1): 136–154.